Showing 1 - 1 results of 1 for search '"HER2-low advanced breast cancer"', query time: 1.31s Refine Results
  1. 1
    Trastuzumab deruxtecan versus chemotherapy for patients with HER2-low advanced breast cancer: A US-based cost-effectiveness analysis

    Trastuzumab deruxtecan versus chemotherapy for patients with HER2-low advanced breast cancer: A US-based cost-effectiveness analysis by Youwen Zhu, Youwen Zhu, Kun Liu, Kun Liu, Xiaolu Zhu, Xiaolu Zhu, Qun Qin, Qun Qin, Hong Zhu, Hong Zhu

    Published 2022-10-01
    Subjects: “…HER2-low advanced breast cancer…”
    Get full text
    Article

Search Tools: